KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97

ABSTRACTCeftazidime-avibactam (CZA) therapy has significantly improved survival rates for patients infected by carbapenem-resistant bacteria, including KPC producers. However, resistance to CZA is a growing concern, attributed to multiple mechanisms. In this study, we characterized four clinical CZA...

Celý popis

Podrobná bibliografie

Hlavní autoři:	María Belén Sanz, Fernando Pasteran, Juan Manuel de Mendieta, Florencia Brunetti, Ezequiel Albornoz, Melina Rapoport, Celeste Lucero, Laura Errecalde, Maria Rosa Nuñez, Renata Monge, Magdalena Pennini, Pablo Power, Alejandra Corso, Sonia A. Gomez
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology 2024-03-01
Edice:	Microbiology Spectrum
Témata:	ceftazidime/avibactam KPC Klebsiella pneumoniae allelic variant
On-line přístup:	https://journals.asm.org/doi/10.1128/spectrum.04111-23
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!